Study to Assess the Effectiveness of a Omega-3 Enriched Supplement on Chemotherapy Tolerance in Colon Cancer Patients

This study has been terminated.
(Impossibility to accomplish the sample size in assigned time.)
Sponsor:
Collaborator:
Abbott
Information provided by (Responsible Party):
Pere Leyes, Hospital Clinic of Barcelona
ClinicalTrials.gov Identifier:
NCT00398333
First received: November 9, 2006
Last updated: April 30, 2013
Last verified: April 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: March 2008
  Primary Completion Date: March 2008 (Final data collection date for primary outcome measure)
Publications: